Ligand Pharmaceuticals LGND Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's software and technology licenses, net?
- Ligand Pharmaceuticals (LGND) reported software and technology licenses, net of $12.99M in Q1 2026.
- How has Ligand Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Ligand Pharmaceuticals's software and technology licenses, net increased by 64.6% year-over-year, from $7.89M to $12.99M.
- What is the long-term trend for Ligand Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's software and technology licenses, net has grown at a 24.1% compound annual growth rate (CAGR), from $4.27M to $12.58M.